Assyro AI

Orange Book product · Generic (ANDA)

OSELTAMIVIR PHOSPHATE

OSELTAMIVIR PHOSPHATE

Generic (ANDA)ANDA 217133TE ABRX BEIJING JIALIN
View OSELTAMIVIR PHOSPHATE familyOpen on FDA Orange Book

At a glance

Oct 30, 2024

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 30, 2024

    1 yr 8 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

OSELTAMIVIR PHOSPHATE

Strength

EQ 30MG BASE

Dosage form

CAPSULE

Route

ORAL

TE code

AB

Application

ANDA 217133

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of OSELTAMIVIR PHOSPHATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo